Weekly Dose of Optimism #194
Eli Lilly's Phase 3 trial for retatrutide has shown remarkable results in weight loss for adults with obesity. Participants lost an average of 28.3% of their body weight over 80 weeks, with significant improvements in various health markers. Additionally, Colossal Biosciences has successfully hatched chicks from fully artificial eggs, marking a significant milestone in biotechnology.
- ▪Eli Lilly reported that participants in the retatrutide trial lost an average of 28.3% of their body weight over 80 weeks.
- ▪The trial also showed significant drops in blood pressure, triglycerides, and waist circumference.
- ▪Colossal Biosciences announced the hatching of 26 healthy chicks from fully artificial eggs.
Not Boring files mainly under business. We currently carry 7 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Not Boring |
| Canonical URL | https://www.notboring.co/p/weekly-dose-of-optimism-194 |
| Publication time | Fri, 22 May 2026 12:51:22 GMT |
| Retrieval time | 2026-05-22T12:57:02.307Z |
| Last seen | 2026-05-22T12:57:02.307Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | v5vLR0NdB68p |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Weekly Dose of Optimism #194Reta Phase 3, Colossal Eggs, SpaceX, OpenAI x Erdős, SendCutSend + Extra DosesMay 22, 2026∙ PaidShareHi friends 👋,Happy Friday and welcome to our 194th Weekly Dose of Optimism. I’m emailing you from beautiful Utah, where I attended the Abundance Institute Gala last night and got to talk nuclear with Oklo’s Jake DeWitte and General Matter’s Scott Nolan, and where I’ll be spending today at the state’s Operation Gigawatt Conference. It’s hard not to feel the optimism in the mountain air. When we started writing the Dose a few years back, nuclear was a controversial dream. Today, we’re heading into the Memorial Day Weekend that kicks off the summer during which multiple new reactors will go critical for the first time.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Not Boring.
